Replies to post #26239 on Biotech Values

[Praveen]

ANDS/HepC

Hi Jellybean,

I Like ANDS and TLR tech for HepC.Also the big novartis deal to back up.It will be a big market if they are able to replace the interferon part.comparable efficacy, but if it can reduce the se of interferons like Flu like symptoms, depression etc, it will be a big plus. I held it from 8-14 and sold it to concentrate my portfolio.I also like coley in the same space but it seems that the coley's drug is going to be an addition rather than replacing the ifn part.

Still early and have to see the phase 1B results...

Regards,
Praveen